Our research group focuses on developing translational nanomedicine and stem cell therapies for treatment of neurological disorders through a unique combination of neuroscience, stem cell biology, cancer biology, and emerging nanotechnology. The ultimate goal of our research is to establish more effective methods to treat these diseases.
For more information about our research, please check the Research section.
About Jiangbing Zhou
Professor Jiangbing Zhou earned his B.S. degree in Chemical Engineering from East China University of Science and Technology in 1998, and his M.S. degree in Biochemistry and Molecular Biology from Tsinghua University in 2001. He entered the graduate program at Johns Hopkins University in 2002, where he studied the biology of breast cancer stem cells and graduated with a Ph.D. degree in Molecular Microbiology and Immunology. He joined the Saltzman group at Yale Biomedical Engineering as a postdoctoral associate in 2008 where he designed and synthesized nanoparticles for locoregional drug delivery to the brain and for gene delivery. After completing his postdoctoral training, he was appointed Associate Research Scientist in 2011 and then Assistant Professor in 2012 at the Yale School of Medicine. In his independent research laboratory, he plans to integrate his previous interdisciplinary trainings in chemistry, engineering, and biology to develop novel therapies to treat selected neurological disorders.